In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and ...
The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...
Zacks.com on MSN
BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe
BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing ...
Gorakhpur: Conventional smear microscopy, though widely used in India, misses detection of many tuberculosis (TB) cases, ...
Co-Diagnostics, Inc. ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has ...
Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...
As Nigeria continues its fight against HIV/AIDS, persistent social stigma remains a major barrier to early diagnosis and ...
The new cobas® 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput, run flexibility, enables sample ...
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...
OverviewThe global infectious disease diagnostics market is poised for steady expansion, with forecasts indicating a CAGR of approximately 7% over the next five years. This growth trajectory is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results